Reduced Fasting And Postprandial Triglyceride Levels By Alirocumab In Male Diabetes Patients On Intensive Insulin Treatment By Improved Chylomicron Metabolism
| Autor: | W. W. de Herder, Monique T. Mulder, S. Fernandez Arroyo, Jeannine Huisbrink, Nadine Pouw, G.-J. M. van de Geijn, Erwin Birnie, Patrick C.N. Rensen, L. van Vark-van der Zee, M. Castro Cabezas, Benjamin Burggraaf, E. van der Zwan |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Triglyceride business.industry Insulin medicine.medical_treatment Metabolism medicine.disease chemistry.chemical_compound Postprandial Endocrinology chemistry Internal medicine Diabetes mellitus medicine Cardiology and Cardiovascular Medicine business Alirocumab Chylomicron |
| Zdroj: | Atherosclerosis. 287:e44 |
| ISSN: | 0021-9150 |
| DOI: | 10.1016/j.atherosclerosis.2019.06.126 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect